Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01162031
Recruitment Status : Withdrawn (no accrual)
First Posted : July 14, 2010
Last Update Posted : May 21, 2018
Sponsor:
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : July 2011
  Actual Study Completion Date : July 2011